Tax or exercise withholding
Jonathan Wygant
VP, Chief Accounting Officer
Common Stock
- Value context
- $61.08K
- Reported price
- $44.88 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
VERACYTE, INC.
Last 30 daysNo qualifying insider buying. Sales: $365.35K by 2 insiders.
Showing the first 6 of 20 trades on this page.
VP, Chief Accounting Officer
Common Stock
Global Chief Commercial Off
Common Stock
Chief Scientific & Med Officer
Common Stock
Chief Financial Officer
Common Stock
EVP, General Counsel
Common Stock
Chief Executive Officer
Common Stock
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
EVP, General Counsel
Common Stock
VP, Chief Accounting Officer
Common Stock
Chief Financial Officer
Common Stock
Chief Scientific & Med Officer
Common Stock
Chief Executive Officer
Common Stock
Chief Executive Officer
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| VP, Chief Accounting Officer | Common StockExercise-price or tax withholding | 1,361$44.88 / share | $61.08K | Sep 2Filed Sep 4 · 2d later | SEC filing |
| Global Chief Commercial Off | Common StockExercise-price or tax withholding | 3,961$44.88 / share | $177.77K | Sep 2Filed Sep 4 · 2d later | SEC filing |
| Chief Scientific & Med Officer | Common StockExercise-price or tax withholding10b5-1 | 3,639$44.88 / share | $163.32K | Sep 2Filed Sep 4 · 2d later | SEC filing |
| Chief Financial Officer | Common StockExercise-price or tax withholding10b5-1 | 3,603$44.88 / share | $161.7K | Sep 2Filed Sep 4 · 2d later | SEC filing |
| EVP, General Counsel | Common StockExercise-price or tax withholding10b5-1 | 3,215$44.88 / share | $144.29K | Sep 2Filed Sep 4 · 2d later | SEC filing |
| Chief Executive Officer | Common StockExercise-price or tax withholding | 8,782$44.88 / share | $394.14K | Sep 2Filed Sep 4 · 2d later | SEC filing |
| Director | Common StockGrant or award | 5,272Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Common StockGrant or award | 5,272Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Common StockGrant or award | 5,272Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Common StockGrant or award | 5,272Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Common StockGrant or award | 5,272Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Common StockGrant or award | 5,272Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Common StockGrant or award | 5,272Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Common StockGrant or award | 5,272Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| EVP, General Counsel | Common StockExercise-price or tax withholding10b5-1 | 3,292$47.80 / share | $157.36K | Jun 2Filed Jun 4 · 2d later | SEC filing |
| VP, Chief Accounting Officer | Common StockExercise-price or tax withholding | 1,361$47.80 / share | $65.06K | Jun 2Filed Jun 4 · 2d later | SEC filing |
| Chief Financial Officer | Common StockExercise-price or tax withholding10b5-1 | 3,693$47.80 / share | $176.53K | Jun 2Filed Jun 4 · 2d later | SEC filing |
| Chief Scientific & Med Officer | Common StockExercise-price or tax withholding10b5-1 | 3,730$47.80 / share | $178.29K | Jun 2Filed Jun 4 · 2d later | SEC filing |
| Chief Executive Officer | Common StockExercise-price or tax withholding10b5-1 | 9,012$47.80 / share | $430.77K | Jun 2Filed Jun 4 · 2d later | SEC filing |
| Chief Executive Officer | Common StockOption exercise or conversion10b5-1 | 138,051$36.60 / share | $5.05M | Jun 4Filed Jun 4 · 0d later | SEC filing |
Showing the latest 20 of 25 trades. Show all 25 trades
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Veracyte, Inc. - Common Stock (VCYT) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberVeracyte, Inc. - Common Stock (VCYT) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberVeracyte, Inc. - Common Stock (VCYT) · Stock
The filing reports a partial sale for the member.
Gilbert CisnerosReporting House member